학술논문
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
2296634X